Comments on: InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program https://mjshareholders.com/inmed-pharmaceuticals-announces-transition-to-a-single-cannabinoid-investigational-drug-candidate-inm-755-for-its-epidermolysis-bullosa-program/ The Ultimate Marijuana Business Directory Sun, 17 Mar 2019 14:45:27 +0000 hourly 1 https://wordpress.org/?v=6.5.5